What is Scynexis Inc (SCYX) stock price today?

Scynexis Inc (SCYX) currently trades at $0.93 per share. The stock has a market capitalization of $78.31M and a P/E ratio of —x.

Is SCYX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Scynexis Inc has a Smart Value Score of 46/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Scynexis Inc's revenue and earnings?

Scynexis Inc has trailing twelve-month (TTM) revenue of $20.60M with profit margins of -41.80%. Earnings per share (EPS) is $-0.17.

Is SCYX stock overvalued or undervalued?

Based on our DCF model, Scynexis Inc's intrinsic value is $1.11, representing a margin of safety of 29.99%. The stock currently trades at a P/E of —x.

SCYX

Scynexis Inc

NASDAQ: SCYX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.93

-0.46% today

Updated 2026-04-30

Market cap

$78.31M

P/E ratio

—

P/S ratio

3.80x

EPS (TTM)

$-0.17

Dividend yield

—

52W range

$1 – $1

Volume

0.6M

Market cap

$78.31M

P/E ratio

—

P/S ratio

3.80x

EPS (TTM)

$-0.17

Dividend yield

—

52W range

$1 – $1

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

4.0

Profitability

6.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$3.47

+273.44%

12-Month target

—

Intrinsic (DCF)

$1.11

Margin of safety

+29.99%

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $18.40M — positive

+ Revenue growth 1,809.00% QoQ

+ 29.99% below intrinsic value

Risks

- Thin margins at -41.80%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$5.09M	$140.14M	$3.75M	$20.60M	$20.60M
Net income	$-62.81M	$67.04M	$-21.29M	$-8.61M	$12.26M
EPS	—	—	—	—	$-0.17
Free cash flow	$-79.89M	$0.00	$-24.01M	$-5.28M	$18.40M
Profit margin	-1,233.73%	47.84%	-568.29%	-41.79%	-41.80%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SCYX	$78.31M	46	8.0	4.0	6.0	5.0	+29.99%	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Scynexis Inc trades at $0.93. Our Smart Value Score of 46/100 indicates the stock is fair. TTM revenue stands at $20.60M. with profit margins at -41.80%. Our DCF model estimates intrinsic value at $1.11.

Frequently asked questions

What is Scynexis Inc's stock price?

Scynexis Inc (SCYX) trades at $0.93.

Is Scynexis Inc overvalued?

Smart Value Score 46/100 (Grade C, Sell). DCF value $1.11.

What is the price target of Scynexis Inc (SCYX)?

The analyst target price is $3.47, representing +273.4% upside from the current price of $0.93.

What is the intrinsic value of Scynexis Inc (SCYX)?

Based on our DCF model, intrinsic value is $1.11, a +30.0% margin of safety versus $0.93.

What is Scynexis Inc's revenue?

TTM revenue is $20.60M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio3.80x

ROE-16.50%

Beta1.15

50D MA$0.90

200D MA$0.79

Shares out0.08B

Float0.03B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SCYX vs LLY →SCYX vs JNJ →SCYX vs ABBV →Stock screener →